Autoantibodies Against Specific Cytokines in Adults With Severe Mycobacterial Infection

Mycobacterium Infection Clinical Trial

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01628744
• Other study ID #: DMR-99-IRB-075-1
• Status: Recruiting
• Phase: N/A
• First received: June 24, 2012
• Last updated: June 26, 2012
• Start date: January 2011
• Est. completion date: December 2014

Study information

• Verified date: June 2012
• Source: China Medical University Hospital
• Contact: Cheng-?Lung KU, Ph.D
• Phone: (886) (0)3 211-8800
• Email: clku[@]mail.cgu.edu.tw
• Is FDA regulated: No
• Health authority: Taiwan: Department of Health
• Study type: Observational

Clinical Trial Summary

In adult, the prevalence of mycobacterial infections is increased with age is largely unknown. IFN-gamma-IL-12/23 axis or NF-kappaB pathways might also plays crucial roles in adult against mycobacteria. Based on this hypothesis, the investigators had applied a functional assay to these pathways in patients with mycobacterial infection.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: December 2014
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Patients with mycobacterial infection

Exclusion Criteria:

• Malignancy

• Severe autoimmune

• HIV infection

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Mycobacterium Infection
• Mycobacterium Infections

Locations

Country	Name	City	State
Taiwan	Graduate Institute of Clinical Medical Science, China Medical University	Taichung

Sponsors (1)

Lead Sponsor	Collaborator
China Medical University Hospital

Country where clinical trial is conducted

Taiwan,